Warning: The NCBI web site requires JavaScript to function. more...
Vaccinia virus
The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.
Year introduced: 1963
protein kinase 2, Vaccinia virus [Supplementary Concept]
amino acid sequence in first source
Date introduced: October 9, 1995
H5R protein, Vaccinia virus [Supplementary Concept]
an early-late 22-kDa protein that migrates at 35-kDa on SDS-PAGE; from vaccinia virus; amino acid sequence in first source
Date introduced: March 10, 1995
early transcription factor protein, Vaccinia virus [Supplementary Concept]
virus-encoded heterodimer; amino acid sequence given in first source
Date introduced: July 10, 1990
L1R protein, Vaccinia virus [Supplementary Concept]
MW 25 kDa; specifically associated with one or more of the membranes enveloping various infectious forms of vaccinia virus virions; has been sequenced
Date introduced: July 12, 1994
p37 protein, Vaccinia virus [Supplementary Concept]
has been sequenced
Date introduced: January 10, 1994
GAAP protein, vaccinia virus [Supplementary Concept]
Date introduced: March 24, 2007
I1 protein, vaccinia virus [Supplementary Concept]
required for assembly of mature virions; amino acid sequence in first source; GenBank M35027
Date introduced: December 22, 1997
DNA polymerase, vaccinia virus [Supplementary Concept]
a 110-116 kDa protein isolated from vaccinia virus-infected cells; has an inherent 3'-5' exonuclease activity; amino acid sequence has been determined
Date introduced: December 23, 1994
42kDa protein, Vaccinia virus [Supplementary Concept]
amino acid sequence given in first source
Date introduced: June 11, 1992
VB1R protein, Vaccinia virus [Supplementary Concept]
a 34 kDa polypeptide that functions as a serine/threonine protein kinase; has been sequenced
Date introduced: May 13, 1992
immunodominant protein p35, vaccinia virus [Supplementary Concept]
Date introduced: February 26, 1992
complement-control protein, Vaccinia virus [Supplementary Concept]
amino acid sequence has been determined; secreted from infected cells; has sequence similarities to members of a gene family that includes complement control proteins
Date introduced: December 26, 1990
capping enzyme, vaccinia virus [Supplementary Concept]
consists of EC 2.7.7.50, EC 2.1.1.56, & RNA triphosphatase
Date introduced: January 22, 1981
Dual Specificity Phosphatase 3
A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for EXTRACELLULAR SIGNAL-REGULATED MAP KINASES.
Year introduced: 2008(1994)
D8L protein, vaccinia virus [Supplementary Concept]
potentially useful in vaccines; N-terminal amino acid sequence in first source
Date introduced: April 13, 2008
A27 protein, vaccinia virus [Supplementary Concept]
binds glycosaminoglycans to aid virus in binding cells
Date introduced: February 7, 2008
D10 protein, vaccinia virus [Supplementary Concept]
an mRNA decapping enzyme used to control host and viral gene expression
Date introduced: May 13, 2007
A33R protein, Vaccinia virus [Supplementary Concept]
isolated from Vaccinia virus; amino acid sequence in first source
Date introduced: February 15, 2002
envelope H3L protein, Vaccinia virus [Supplementary Concept]
binds cell surface heparan sulfate; amino acid sequence in first source
Date introduced: April 4, 2000